Atom
Product
Blog
Pricing
Webinars
Sign in
Book Demo
Eligibility
Profile
Finance
Other
Similar Grants
State Opioid Response Grants | Atom
Back
State Opioid Response Grants
Due: Jul 1, 2024
HHS-SAMHS-SAMHSA
$1,480,500,000
Description
The purpose of this program is to address the public health crisis caused by escalating opioid misuse, opioid use disorder (OUD), and opioid-related overdose across the nation. States and territories are expected to use the resources to:(1) increase access to U.S. Food and Drug Administration (FDA)-approved medications for the treatment of opioid use disorder (MOUD); (2) support the continuum of prevention, harm reduction, treatment, and recovery support services for OUD and other concurrent substance use disorders; and (3) suppo...
Read more
Estimated Total Program Funding
$1,480,500,000
Expected Number of Awards
59
Award Ceiling
$1,480,500,000
Eligible Applicants
- Others
Additional Eligibility Information
Eligibility is limited to Single State Agencies (SSAs) and territories.
Funding Type
Grant
Categories of Funding Activity
- Health
Opportunity Type
Discretionary
Grantor Contact Information
OPIOIDSOR@samhsa.hhs.gov
Other Grantor Informaiton
Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration (240) 276-0300
Additional information
State Opioid Response Grants
Supporting Link
https://www.samhsa.gov/grants/grant-announcements/ti-24-008
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
Similar Grants
Effective Models to Address Mental Health and Substance Use Disorders: Strategies for Successful and Equitable Abatement Using Opioid Settlement Dollars
Rolling Submissions
NASEM
Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes.
Rolling Submissions
HHS-FDA
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
Due: Jan 16, 2026
HHS-NIH11